Potency and Resistance Analysis of Hepatitis C Virus NS5B Polymerase Inhibitor BMS-791325 on All Major Genotypes

Liu, M., Tuttle, M., Gao, M., & Lemm, J. A. (2014).

Impairment of Type I but Not Type III IFN Signaling by Hepatitis C Virus Infection Influences Antiviral Responses in Primary Human Hepatocytes

Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., Rosain, J., Bilguvar, K., Ye, J., Bolze, A., Bigio, B., Yang, R., Arias, A. A., Zhou, Q., Zhang, Y., … Casanova, J.-L. (2020).

HCV Genotyping from NGS Short Reads and Its Application in Genotype Detection from HCV Mixed Infected Plasma

Qiu, P., Stevens, R., Wei, B., Lahser, F., Howe, A. Y. M., Klappenbach, J. A., & Marton, M. J. (2015).

Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population

Zhao, S., Sinson, J. C., Li, S., Liu, P., & colleagues. (2025).

Detection of in vivo hepatitis B virus surface antigen mutations—A comparison of four routine screening assays

Gencay, M. M., Kaminski, W. E., Westergaard, G., Pabinger, S., Kriegner, A., Nauck, M., Seffner, A., Gohl, P., Hübner, K., & Gohl, P. (2018).

Preclinical Characterization of BMS-791325, an Allosteric Inhibitor of Hepatitis C Virus NS5B Polymerase

Lemm, J. A., Liu, M., Gentles, R. G., Ding, M., Voss, S., Pelosi, L. A., Wang, Y. K., Rigat, K., Mosure, K. W., Bender, J. A., Colonno, R. J., Meanwell, N. A., Kadow, J. F., Santone, K. S., Roberts, S. B., & Gao, M. (2014).

Comparison of Daclatasvir Resistance Barriers on NS5A from Hepatitis C Virus Genotypes 1 to 6: Implications for Cross-Genotype Activity

Wang, C., Jia, L., O’Boyle, D. R., II, Sun, J.-H., Rigat, K., Valera, L., Nower, P., Huang, X., Kienzle, B., Roberts, S., Gao, M., & Fridell, R. A. (2014).